All News
Can you engage patients in research?
You can, and you should! Vincent DelGaizo shows various studies in which patients participated in the design, recruitment, survey and material creation. Resulted in some of the most successful studies in #pedirheum! #ACR19 @RheumNow @carrainc https://t.co/QQdF4fuqSh
Jonathan Hausmann MD hausmannMD ( View Tweet)
Gout tip: If you have a “failed” MTP aspirate, blow out end of needle onto a slide and examine it. #ACR19 @RheumNow #gout
Maeve Gamble MaeveGamble ( View Tweet)
abstract L04 shoes increase risk of CV disease in patients who have calcium pyrophosphate deposition dz. A VA study of 24,000 males shows higher rates of MI, CVA, coronary syndrome and all-mortality with HR = 1.26 - 2.92 increase #ACR19 https://t.co/Gv4NLTc0NY
Dr. John Cush RheumNow ( View Tweet)
Apparently some actual published data of benefit of wearables in RA improving FATIGUE. See reference on slide
#ACR19 @rheumnow 5T027 https://t.co/WqBQ9neQGp
Dr Irwin Lim _connectedcare ( View Tweet)
#acr19 @RheumNow Pearls by Dr Sterling West
1. For pts with gout: as about energy drink consumption
2. Dry joint tap- blow out needle onto the slide
3. Consider CPPD in pts with “seroneg RA”- May not have typical acute flare
k dao KDAO2011 ( View Tweet)
In our chronic disease cohort, the accuracy of wearables in measuring steps can be poor. Different gait types & speed affects measurement.
Important for validity
#ACR19 @rheumnow 5T027
Dr Irwin Lim _connectedcare ( View Tweet)
Anyone who says that rheumatic irAEs aren’t a serious irAE hasn’t met my pts, or @cappelliMD’s, or @CCalabreseDO’s @LCalabreseDO’s, or ⬇️list.
It can be at least as brutal as the cancer, so my pts tell me, & @jhrheumatology has the numbers to prove it.
#ACR19 ABST2151 @RheumNow https://t.co/nxOCvrLWqa
David Liew drdavidliew ( View Tweet)
Dr. Carol Langford from @ClevelandClinic speaking at #ACR19 @ABIMcert #Rheumatology Update
🚨 All #ACR19 Attendees 🚨
You can earn up to 53.25 MOCs by attending the meeting but must claim by 12/31/2019
@RheumNow @ACRheum @ABIMFoundation https://t.co/RvhHiKmOZx
Adam Kilian MD KilianMD ( View Tweet)
#acr19 @RheumNow Pearls by Dr Sterling West
1. Pain w/ measuring BP (BP cuff test) sens 69%, spec 80%= FM
2. Recurrent troch/anserine bursitis - take off shoes and watch them walk might see hallux rigidis, over pronation- (my hint: look for leg length discrepancy as well)
k dao KDAO2011 ( View Tweet)
#acr19 @RheumNow Pearls by Dr Sterling West: mnemonics to help with dermatomes —- trainees these have been on the boards!!! https://t.co/2yZ39fIYfQ
k dao KDAO2011 ( View Tweet)
Wow. When can we have the mouthguard to measure uric acid levels?
#ACR19 @rheumnow 5T027 https://t.co/L5ytR1jxJT
Dr Irwin Lim _connectedcare ( View Tweet)
Likely to be practice-changing one day - abstr#2091 shows increased seroprotection w/high dose influenza vaccine in RA patients, including those <65 yrs
@RheumNow #ACR19 #whyivaccinate
Cassandra Calabrese CCalabreseDO ( View Tweet)
My write-up of data on IL-17 Inhibitors In Non-Radiographic Axial SpA presented here at #ACR19 @rheumnow https://t.co/5emwrGX6zF
Philip Robinson philipcrobinson ( View Tweet)
RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow and its faculty.
Dr. John Cush RheumNow ( View Tweet)
Exciting *US orderable* new bio marker in #lupus CB-CAPS = cell bound complement activation products. Nicely tracks disease #ACR19 @RheumNow https://t.co/J1pmyGqmyY
Philip Robinson philipcrobinson ( View Tweet)
#acr19 @rheumnow Hench lecture: Dr Reveille
HLAB15 may be a marker for peripheral arthritis in pts w/AS (OR 1.9)
k dao KDAO2011 ( View Tweet)
Bullish on value of Polygenic Risk scores to help diagnose Axial SpA (not commercially available yet)
#ACR19 @rheumnow 5T004 Reveille https://t.co/OfQYzx6yGL
Dr Irwin Lim _connectedcare ( View Tweet)
VERVE results - Live zoster vaccine safe and effective in >600 patients with autoimmune diseases treated wth TNFi abstr#0824 @RheumNow #ACR19
Cassandra Calabrese CCalabreseDO ( View Tweet)
Buyon reminds us how highly sensitive ELISA based anti-DNA assays are, caution required because more sensitive tests are often negative (crithidia/RIA) #ACR19 @RheumNow Abs 5T002 https://t.co/XN8Sfy1yHJ
Philip Robinson philipcrobinson ( View Tweet)
2.9% of this cohort had ONSET of Inflammatory Back pain after age of 50. We don’t study this group.
#ACR19 @rheumnow 5T004 Reveille https://t.co/p023BlGxPN
Dr Irwin Lim _connectedcare ( View Tweet)
